Trial Profile
An Open Label, Sequential, Single Cohort, Repeat Dose Study to Investigate the Potential Interaction of GSK2190915 on the Pharmacokinetics of Rosuvastatin in Healthy Adult Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Fiboflapon (Primary) ; Rosuvastatin
- Indications Asthma; Atherosclerosis; Cardiovascular disorders; Hyperlipidaemia
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 11 Aug 2011 New trial record